- American City Business Journals•2 hours ago
Earnings season for our Massachusetts biotech giants kicks off this week when Vertex Pharmaceuticals reports its third quarter financials on Tuesday evening, followed by Biogen on Wednesday morning. While probably just a fluke, it’s unusual for Vertex (VRTX) to be the first local biotech to give a quarterly update, as that honor usually goes to Biogen (BIIB). Vertex : To some extent, the financial news expected from the Boston-based company is already old news.
- 24/7 Wall St.•10 hours ago
Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of the other top players in the health care sector.
- GlobeNewswire•2 days agoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of a Class Action Lawsuit – BIIB
NEW YORK, Oct. 21, 2016-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired securities of Biogen Inc. between July 23, 2014 ...
Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||289.00 x 200|
|Ask||305.00 x 100|
|Day's Range||289.78 - 300.32|
|52wk Range||223.02 - 333.65|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||16.98|
|Avg Vol (3m)||1,568,714|
|Dividend & Yield||N/A (N/A)|